Good morning :)
Place Order
Add to Watchlist

Poly Medicure Ltd

POLYMED

Poly Medicure Ltd

POLYMED
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹23,342 cr, stock is ranked 312
Moderate RiskStock is 2.65x as volatile as Nifty
2,338.251.46% (+33.75)
2,338.251.46% (+33.75)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹23,342 cr, stock is ranked 312
Moderate RiskStock is 2.65x as volatile as Nifty

How to use scorecard? Learn more

Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹23,342 cr, stock is ranked 312
Moderate RiskStock is 2.65x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
86.5818.800.12%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
49.936.390.52%

Forecast & Ratings

Detailed Forecast 
80%
Analysts have suggested that investors can buy this stock

from 5 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Poly Medicure Limited is engaged in the manufacturing and sale of medical devices.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 17.91%, vs industry avg of 17.95%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 46.07% to 48.27%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 31.6%, vs industry avg of -1.79%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue420.52468.95536.04630.50707.84808.20963.411,153.341,437.071,504.51
Raw Materialssubtract147.68119.62176.07165.66178.89214.22296.55345.371,017.571,064.80
Power & Fuel Costsubtract15.2216.7819.0424.7425.6225.2729.8438.59
Employee Costsubtract74.7787.2699.13116.61138.76141.76163.62202.75
Selling & Administrative Expensessubtract39.2347.0845.2458.0561.0356.2066.9777.78
Operating & Other expensessubtract47.6190.8058.98114.53116.82132.53151.07183.34
Depreciation/Amortizationsubtract21.0323.7329.2437.2940.5347.5253.9557.1763.9368.05
Interest & Other Itemssubtract9.958.4911.5813.5320.4810.646.1610.8611.3011.97
Taxes & Other Itemssubtract16.7720.0626.1634.6729.8544.1848.7458.2186.0190.08
EPS5.476.258.007.4110.8614.7615.2818.6926.9228.10
DPS1.502.502.002.002.002.502.503.003.003.00
Payout ratio0.270.400.250.270.180.170.160.160.110.11

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

May 25PDF
Feb 4PDF
FY 2022

Annual report

PDF

Investor Presentation

May 24PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHealth Care Equipment & Supplies

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Poly Medicure Ltd90.3818.800.12%
Tarsons Products Ltd55.774.180.45%
Borosil Scientific Ltd75.934.75
Balaxi Pharmaceuticals Ltd-243.212.90

Price Comparison

Compare POLYMED with any stock or ETF
Compare POLYMED with any stock or ETF
POLYMED
Loading...

Shareholdings

Promoter Holdings Trend

Increased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 9.41%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Increased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has increased by 1.19%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding62.56%7.24%5.24%11.10%13.87%

Dec 2023

Mar 2024

Jun 2024

Aug 2024

Shareholding History

JunSepDec '23MarJunAug15.61%14.49%14.10%12.38%9.91%11.10%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Poly Medicure Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Quant Small Cap Fund - Growth - Direct Plan

Growth
2.1764%2.21%0.78%7/119 (+6)
UTI Flexi Cap Fund - Growth - Direct Plan

Growth
1.3712%1.21%-0.01%36/68 (-1)
Quant Active Fund - Growth - Direct Plan

Growth
0.1924%0.40%0.40%74/85 (+7)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Poly Medicure Ltd

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

POLYMED has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.12%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.23 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 21, 2023

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Sep 21, 2023

Cash Dividend

Ex DateEx DateSep 16, 2022

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Sep 16, 2022

Cash Dividend

Ex DateEx DateSep 16, 2021

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Sep 16, 2021

Cash Dividend

Ex DateEx DateFeb 27, 2020

Interim
Interim | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Feb 27, 2020

Cash Dividend

Ex DateEx DateSep 13, 2019

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 13, 2019

News & Opinions
Spotlight
Poly Medicure edges higher after raising Rs 1,000 crore via QIP issue

The company has allotted 53.19 equity shares to qualified institutional investors, the shares were priced at Rs 1,880 apiece, resulting in an issue size of approximately Rs 1,000 crore. The QIP garnered interest from a diverse range of investors, including long-only funds, mutual funds, insurance companies, and other key stakeholders. The QIP witnessed participation from various institutional investors, with the allottees receiving more than 5% of the total issue size. Lighthouse India Fund received 20% allocation from the total issue, followed by SBI Mutual Fund (13%) and Nomura Funds Ireland (10.50%), Further, ICICI Prudential Life Insurance Company, Kotak Mahindra Life Insurance Company, Quant Mutual Fund, Max Life Insurance Company received an allocation of 5% each. Poly Medicure intends to use the proceeds from the issue for funding capital expenditure to be incurred by the company for setting up of manufacturing facilities, pursuing inorganic initiatives; and general corporate purposes. Poly Medicure manufactures disposable medical items, such as IV cannula, blood bags, blood collection tubes, and infusion and transfusion sets. Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Poly Medicure launches QIP issue

Poly Medicure has launched a qualified institutional placement of equity shares of face value of Rs 5 each with floor price of Rs 1880.6875 per equity share on 19 August 2024. Powered by Capital Market - Live

1 week agoCapital Market - Live
Expect Exports To Grow At 25% & Domestic Biz Growth Of 20-22%: Poly Medicure | CNBC TV18
1 month agoCNBC-TV18

Board of Poly Medicure appoints director

1 month agoBusiness Standard

Poly Medicure consolidated net profit rises 18.09% in the June 2024 quarter

1 month agoBusiness Standard
Corporate
Poly Medicure schedules board meeting

Poly Medicure will hold a meeting of the Board of Directors of the Company on 22 July 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live

Volumes spurt at Poly Medicure Ltd counter

2 months agoBusiness Standard

How Himanshu Baid Left High-paying Job In Germany And Built Rs 13,260 Crore Medical Devices Company - News18

10 months agoNews18

Poly Medicure shares jump 4 percent on Investec Buy rating

1 year agoMoneycontrol

Poly Medicure Consolidated June 2023 Net Sales at Rs 320.83 crore, up 28.92% Y-o-Y

1 year agoMoneycontrol